Abstract
Spiders use their venom for defence and to capture prey. These venoms contain a cocktail of biologically active compounds that display several different biological activities, such as large molecules and small molecules including peptides, proteins/enzymes, and other components. Thus, venom constituents have attracted the attention of biochemists and pharmacologists over the years. The brown widow spider (Latrodectus geometricus) is a venomous spider found worldwide, including in Thailand. This spider causes human injuries, and the venom has many potential applications. In this study, we investigated the complexity and pharmacology of brown widow spider venom. Spider crude venom was investigated using partial proteome techniques and enzymatic activity, toxicity, and antibacterial activity assessments. We found that crude venom displayed a wide range of molecular masses from 19 to over 97 kDa, with molecular masses of 66 kDa intensely stained. Peptides and proteins were identified by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS), which showed that the crude venom contained a variety of substances, including latrotoxins, apolipophorins, hemocyanins, chitinases, arginine kinase, allergen antigen 5-like protein, astacin-like metalloproteases, and serine proteases. High hyaluronidase activity was observed based on the turbidimetric method. The venom presented toxicity in crickets (PD50 = 0.73 ± 0.10 μg/g body weight), and substantial envenomation symptoms, such as slow-motion movement, paralysis, and even death, were noted. Moreover, this venom exhibited potential antibacterial activity against the gram-positive Bacillus subtilis but not the gram-negative Pseudomonas aeruginosa. Spider venom contains numerous molecules with biological activity, such as latrotoxins, which affect insects, and enzymes. In addition to latrotoxins, certain enzymes in venom are hypothesized to exhibit toxicity and antimicrobial activity. This study provides important information for the further development of natural compounds or insecticidal toxins.
Keywords: Widow spider, Latrodectus geometricus, Venom, Toxicity, Hyaluronidase, Antibacterial activity
Abbreviations: α-, β-, γ-, δ-, ε-LIT, alpha-, beta-, gramma-, delta-, epsilon-latroinsectotoxins; α-latrocrustotoxin, alpha-latrocrustotoxin; BWSV, brown widow spider venom; kDa, kilodalton; LC-MS/MS, liquid chromatography–mass spectrometry/mass spectrometry; OD600, optical density at 600 nm; PD50, 50% paralytic dose
Highlights
-
•
8 proteins were identified using mass spectrometry.
-
•
Venom exhibited potential hyaluronidase activity and antibacterial activity.
-
•
Crude venom presented toxicity in crickets.
-
•
The venom peptides can develop for a natural lead drug or an insecticidal toxin.
1. Introduction
Venomous animals use their venom for defence and prey capture. The venom contains a complex mixture both of organic and inorganic compounds, such as peptides and proteins, and mainly includes neurotoxins, enzymes, and other components that contribute to the venom functions (Saez et al., 2010). The composition of venom has attracted the interest of biochemists and pharmacologists over the years because the biologically active molecules in venom have potential applications. Although several bioactive components from venomous animals, such as snakes, scorpions, centipedes, cone snails, wasps, and spiders, have been studied, studies on widow spider venom remain limited.
The widow spider is a venomous animal that belongs to the phylum Arthropoda, class Arachnida, order Araneae, family Theridiidae, and genus Latrodectus (Yan and Wang, 2015). This genus contains 32 species (World Spider Catalog, 2020), including black widow spiders, which are known for their venom that contains neurotoxins. Latrodectus spp. are called widow spiders because the female spider eats the male spider after mating. The brown widow spider, Latrodectus geometricus has an orange hourglass on its ventral surface, whereas other species have a red hourglass. Geographically speaking, brown widows are found across the globe (exception of the polar regions) (Choi et al., 2019; Muslimin et al., 2015) and commonly inhabit garages, agricultural areas, and even houses. Unsurprisingly, numerous reports have described the frequency of spider bites and envenomation worldwide (Jelinek, 1997). Spider bites cause local and systemic symptoms, including paralysis, immobilization, sharp pain, diaphoresis, hypertension, headache, and numbness (Duan et al., 2008).
The components of brown widow venom cause massive transmitter release from presynaptic neuron cells by binding receptors, which stimulates both the presence and absence of calcium ions (Ca2+) in neuron cells. Latrotoxins are major toxins present in venom. Seven different latrotoxins have been isolated from black widow spiders (Latrodectus mactans) (Krasnoperov et al., 1990), and they have specific targets. Specifically, α-latrotoxin targets vertebrates, latroinsectotoxins (LITs; α-, β-, γ-, δ-, ε-LIT) target insects, and α-latrocrustotoxin targets crustaceans. α-Latrotoxin acts in vertebrates via both the presence and absence of calcium ions, causing massive neurotransmitter release in neuronal cells. In addition, low molecular weight proteins (LMWPs and LMWP2) have been isolated from the venom and are called latrodectins. These proteins contribute to the neurotoxicity of latrotoxins by increasing their binding to membrane targets (Grishin et al., 1993). In the 2000s, several reports highlighted severe cases of envenomation. In one case report, patients that were bitten by the brown widow spider initially presented local symptoms, such as erythema, oedema, swelling, numbness, and pain at the bite site. After 20 min, the erythema and oedema expanded and the patient started to experience headache, cramps, vomiting, debilitating pain, and fasciculations within 30 min. These symptoms were alleviated after 6 h, and the patient recovered over the following 24 h. In addition to previously reported local symptoms, local burning was also reported during brown widow spider envenomation (Almeida et al., 2009; Goddard et al., 2008; Shackelford et al., 2015).
In the present study, we performed biochemical analyses and antibacterial assays of venom from the brown widow spider L. geometricus. The results indicated that this spider venom contains several compounds and exhibits antibacterial activity, and research on its venom has potential application for the development of peptides as pharmaceuticals and bioinsecticide agents.
2. Materials and methods
2.1. Chemicals
Ammonium bicarbonate (AmB); Bradford reagent; hyaluronidase from bovine testes; N,N,N’N’-tetramethylenediamine (TEMED); iodoacetamide (IAA); and trifluoroacetic acid (TFA) were obtained from Sigma-Aldrich, USA. Sodium dodecyl sulphate (SDS) was obtained from Lobal Chemie, India. Acetonitrile (ACN) was obtained from VWR Chemicals, France. An Amersham™ LMW Calibration Kit for SDS Electrophoresis as a protein standard was obtained from GE Healthcare, UK. Cetyltrimethylammonium bromide (CTAB) was obtained from Panreac AppliChem, Germany. Dithiothreitol (DTT) was purchased from Vivantis, Malaysia. Formic acid was obtained from Fluka, Switzerland.
2.2. Spider venom collection
Brown widow spiders (L. geometricus) were obtained from suburban areas of Khon Kaen city, Khon Kaen Province. All animals received food and were housed under controlled environmental conditions. Briefly, spiders were housed in plastic boxes and fed crickets (Gryllus sp.) twice per week for 3 months under the appropriate conditions (27 ± 1 °C, 60–70% R.H., photoperiod of light:dark cycle 16:8 h) to ensure that adult spiders were used in the studies. Adult female brown widow spiders were not allowed to feed for 1 week before venom collection. For venom collection, the spider venom was obtained using the cold shock method at 4 °C for 1 h followed by −20 °C for 30 min. The venom droplets were collected in a capillary tube that was placed in a microcentrifuge tube that was kept on ice (Khan et al., 2013). Venom was lyophilized and stored at −80 °C until use. The protein content in venom was measured using the Bradford method, and bovine serum albumin (BSA) was used as a standard. An EnSight Multimode Plate Reader (PerkinElmer, USA) was used for the assay, and concentration was expressed as microgram per microliter (μg/μl).
2.3. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and de-staining solution
SDS-PAGE of crude venom was performed under reducing conditions according to the method of Laemmli (1970). The lyophilized venom was dissolved in Milli-Q water and analysed using 13% SDS-PAGE. An AmershamTM LMW Calibration Kit for SDS Electrophoresis (GE Healthcare, UK) was used as the standard protein, and the SDS-PAGE gel was visualized using Coomassie brilliant blue G-250 staining.
2.4. Purification of spider venom using reverse-phase high-performance liquid chromatography
Lyophilized crude venom (2 mg) was dissolved in 200 μl of 0.1% trifluoroacetic acid (TFA) in water. Debris was removed by centrifugation at 10,000×g for 2 min. Separation was performed using a RP-HPLC C18 (0.46 × 25 cm, 5 μm particle size) column. Proteins and/or peptides were eluted at 1 ml/min with a linear gradient of 0.1% TFA in water (solvent A) and 0.085% TFA in acetonitrile (ACN) (solvent B) under the following conditions: 0% B for 10 min, 5–30% over 10 min, 30–50% over 10 min, 50–70% over 40 min, and 70–100% over 10 min. The absorption of proteins and/or peptides was monitored at 214 nm. Then, the fractions were manually collected, lyophilized, and resuspended in sample buffer. SDS-PAGE was performed under reducing conditions, and protein bands were stained with Coomassie brilliant blue G-250 staining before mass spectrometry analysis. Since the RP-HPLC fraction had a low protein concentration, silver staining was used for visualization.
2.5. In-gel digestion with trypsinization
Protein bands were excised from the SDS-PAGE gel and washed three times (10 min, with shaking each time) with 200 μl of deionized water and then AmB, AmB/ACN (1:1) and ACN, and gel bands were dried for 5 min. Subsequently, 100 μl of 10 mM DTT/20 mM AmB was added. Following incubation at 56 °C for 45 min, 100 μl of 55 mM iodoacetamide (IAA)/20 mM AmB was added, and incubation was continued in dark conditions at room temperature for 30 min. A 200 μl aliquot of 20 mM AmB/ACN (1:1) was then added, and the tube was shaken for 10 min (repeated once). Then, 200 μl of ACN was added and shaken for 10 min. Gel bands were dried for 5 min, and then 20–40 μl of freshly prepared enzyme solution (trypsin) was added, and the tube was incubated at 4 °C for 30 min. After liquid phase removal, 5–10 μl of 25 mM AmB was added and incubated at 37 °C overnight. Then, 50 μl of 20 mM AmB, extraction buffer 1 and extraction buffer 2 were added sequentially, the tube was shaken for 10 min, and the liquid phase was retained following each addition of solution. The mixture was dried in a SpeedVac Vacuum Concentrators (Thermo Scientific, USA) at 45 °C for 120 min. The pellet was collected, and then 30–40 μl of resuspension buffer (ACN and formic acid) was added to the pellet. The solution was centrifuged at 10,000 rpm at room temperature for 10 min before being injected into an LC-MS instrument or kept at −70 °C until used (Heawchaiyaphum et al., 2018).
2.6. Protein identification with LC-MS/MS and data search
For the LC-MS/MS analysis, the samples were analysed using a nano-liquid chromatography system (EASY-nLC II, Bruker) coupled to a Q-TOF mass spectrometer (MicrOTOFQ-II, Bruker) equipped with an ESI nano-sprayer. The instrument was maintained and operated at the Khon Kaen University Research Instrument Center, Thailand. The ESI-Q-TOF instrument was calibrated in the m/z range of 50–3000 using an internal calibration standard (Tune mix solution), which was supplied by Agilent. Sample volumes of 3–6 μl were loaded by the autosampler onto an EASY-Column (10 cm, ID 75 μm, 3 μm, C18-A2; Thermo Scientific, USA) using a flow rate of 300 nl/min and a linear gradient from Solution A (0.1% formic acid) to 45% Solution B (0.1% formic acid in ACN) over 45 min. The Bruker Daltonics software package HyStar v.3.2 was used to control the Q-TOF device. LC–MS/MS spectra were analysed using Compass Data Analysis v.4.0.
Protein identification was performed by searching against the NCBIprot (Other Metazoa) protein database using the MASCOT MS/MS Ion Search program (www.matrixscience.com) with the initial searching parameters: enzyme: trypsin; fixed modification: carbamidomethylation (C); variable modification: oxidation (HW) and oxidation (M); peptide mass tolerance: 0.5 Da; fragment mass tolerance: 0.5 Da; peptide charge states: +1, +2, and +3; instrument type: ESI-TRAP; and report top: auto.
2.7. Toxicity
Adult crickets (Gryllus sp.) (average bodyweight, 0.27 g) were intraperitoneally injected with 20 μl of phosphate-buffered saline (PBS) with or without venom. After injection, these crickets were placed in an overturned position in the plastic container, and the mortality, paralysis, and behaviours were monitored within 30 min post-injection. The assay endpoint was the calculation of the 50% paralytic dose (PD50). The PD50 was evaluated using a range of 6 venom doses (0, 0.2, 0.5, 0.8, 1, and 2 μg/g body weight), with 6 crickets per dose (n = 6). Venom-injected crickets that could not turn to a righted position were paralyzed (Uawonggul et al., 2014).
2.8. Hyaluronidase activity
Hyaluronidase activity was measured using the turbidimetric method reported by Villas-Boas et al. (2012), with slight modifications. Briefly, various concentrations of brown widow spider venom (BWSV) (0.21, 0.42, and 0.83 μg/μl) in a volume of 5 μl were mixed with 25 μl of 0.5 mg/ml hyaluronic acid (HA) and acetate buffer (0.2 M sodium acetate, pH 4.0, with 0.15 M NaCl) to a final volume of 50 μl, and this reaction mixture was placed in a microplate. The reactions mixtures were incubated at 37 °C for 30 min. Then, 100 μl of 2.5% CTAB in 2% NaOH was added to stop the reaction. Milli-Q water was used as a blank, and 0.67 μg/μl of hyaluronidase from bovine testes was used as a positive control. The solutions were read at 405 nm in the microplate reader. The specificity was expressed as turbidity reduction units per microgram (TRU/μg).
2.9. Antibacterial activity
Gram-positive (Bacillus subtilis) and gram-negative (Pseudomonas aeruginosa) bacteria were used to investigate the antibacterial activity using the disc diffusion assay. Bacteria were cultured in nutrient broth (NB) medium to the exponential phase (OD600 = 0.5) and swabbed on nutrient agar (NA). Fifteen microliters of venom solution (0, 10, and 30 mg/ml) was dropped onto Whatman filter paper discs (6 mm in diameter) and subsequently placed on NA. The plates were incubated at 37 °C for 24 h to observe the inhibition zone. Ampicillin and streptomycin (10 μg/paper disc (Oxoid, England)) were used as a positive control, and Milli-Q water served as a negative control. Antibacterial activity was evaluated by measuring the inhibition zone diameter in millimetres using a scale. All experiments were performed in triplicate (Lei et al., 2015).
2.10. Statistical analysis
The results were expressed as the mean ± standard error of the mean (S.E.M.). All data were analysed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test using Statistical Package for Social Studies (SPSS) IBM version 22.0 (Armonk, USA). P < 0.05 was considered statistically significant.
3. Results and discussion
3.1. SDS-PAGE of spider venom and LC-MS/MS identification of its separated proteins
The lack of protein information from spider venom has limited our detailed knowledge of brown widow spiders. Although the protein composition of Latrodectus tredecimguttatus venom has been clarified to some extent by a partial proteomic investigation (Duan et al., 2008), the venom from L. geometricus has remained poorly understood. Therefore, in this work, we investigated adult female L. geometricus venom, which was collected using the cold shock method, using proteomic techniques. The collected venom was not contaminated with other components because the spiders were not allowed to feed for 1 week prior to venom collection. Thus, the venom was pure and appropriate for protein identification.
BWSV was investigated by 13% SDS-PAGE performed at 150 V for 120 min to assess the pattern of protein separation. Venom proteins exhibited a wide range of molecular masses from approximately 19.0 to 97.0 kDa and greater than 97.0 kDa. Major protein bands were present at 66.0, 70.0 and over 97 kDa, which were similar to results noted for L. tredecimguttatus venom (43–120 kDa) (Yan et al., 2014). Thus, the venom proteins include large proteins and low-molecular weight proteins or peptides.
To identify the proteins, protein bands were divided into the 1st-7th bands according to obvious separation, mostly high molecular weight proteins were identified, and low molecular weight proteins were not chosen because of overlapping proteins (Fig. 1). These bands were analysed and identified using LC-MS/MS. The results showed that the first band corresponded to apolipophorins and that the second band presented 5.2% sequence coverage with latrotoxins, including latroinsectotoxin, latrocrustatoxin, and latrotoxin. In addition, the electrophoretic pattern of the venom also showed proteins ranging from 110 to 130 kDa, which correspond to the molecular weight of latrotoxins, a major toxin group in the genus Latrodectus (Grishin et al., 1993; Yan and Wang, 2015). According to de Roodt et al. (2017), latrotoxins present an important percentage of the total venom weight, suggesting that L. geometricus venom is rich in toxins. Interestingly, the third and fourth bands corresponded to hemocyanins, which are components of secretory epithelial cells of the venom glands and found in the blood and lymphatic fluids of many arthropod species, including spiders (Smith and Russell, 1966). These results suggested that the proteins were not contaminants from body fluids. In addition, the fifth and sixth bands were correlated with enzymes, i.e., chitinase, astacin-like metalloprotease and arginine kinase. The fifth band presented one unique peptide matched with the chitinase of Araneus ventricosus. The sixth band showed 40% sequence coverage of astacin-like metalloprotease toxin, and 5 unique peptides matched with arginine kinase. These enzymes are also found in other venoms, such as that of Podocoryne carnea (Pan et al., 1998) and Loxosceles intermedia (da Silveira et al., 2006). Finally, the seventh band presented partial coverage of serine protease peptide, and 3 unique peptides were matched (Table 1). Duan et al. (2006) reported that some proteases, such as astacin-like metalloprotease, serine protease, and antigen 5-like protein, are related to the noxious effects of L. tredecimguttatus and Loxosceles venoms. All peptide sequences are available in Supplementary Table 1.
Table 1.
Bands | Protein name | Accession no. | Theoretical MW (kDa)a | Number of unique peptides matched | Protein sequence coverage (%) | Score XCb |
---|---|---|---|---|---|---|
1st | Uncharacterized protein LOC107439767 of Parasteatoda tepidariorum | XP_015907950.1 | 212.279 | 6 | 4.5 | 263 |
1st | Apolipophorins of Parasteatoda tepidariorum | XP_021003806.1 | 366.911 | 2 | 0.6 | 94 |
2nd | α-latroinsectotoxin precursor of Latrodectus tredecimguttatus | CAA78464.1 | 158.449 | 8 | 5.2 | 287 |
2nd | δ-latroinsectotoxin precursor of Latrodectus tredecimguttatus | CAA63363.1 | 136.137 | 4 | 3.9 | 134 |
2nd | α-latrocrustotoxin precursor | Q9XZC0.2 | 158.752 | 3 | 2.9 | 111 |
2nd | α-latrotoxin of Latrodectus hesperus | AGD80166.1 | 154.923 | 4 | 3.8 | 97 |
2nd | α-latrotoxin precursor of Latrodectus tredecimguttatus | CAA38753.1 | 157.386 | 4 | 3.6 | 73 |
3rd | Hemocyanin C chain of Latrodectus hesperus | ADV40153.1 | 37.976 | 12 | 52.0 | 410 |
3rd | Hemocyanin C chain of Parasteatoda tepidariorum | XP_015914467.1 | 78.587 | 13 | 18.7 | 377 |
3rd | Hemocyanin C chain of Stegodyphus mimosarum | KFM75964.1 | 72.640 | 7 | 9.4 | 204 |
3rd | Hemocyanin F chain of Stegodyphus mimosarum | KFM66956.1 | 72.541 | 7 | 11.1 | 158 |
3rd | Hemocyanin subunit F of Nephila inaurata madagascariensis | CAD68056.1 | 72.326 | 6 | 9.9 | 152 |
3rd | Hemocyanin subunit D of Nephila inaurata madagascariensis | CAD68054.1 | 72.483 | 4 | 6.4 | 117 |
3rd | α-latroinsectotoxin precursor of Latrodectus tredecimguttatus | CAA78464.1 | 158.449 | 4 | 2.9 | 113 |
3rd | Hemocyanin subunit F of Euphrynichus bacillifer | CCA94920.1 | 72.485 | 4 | 4.8 | 108 |
3rd | Hemocyanin subunit D of Latrodectus hesperus | ADV40138.1 | 38.235 | 3 | 10.5 | 103 |
3rd | Hemocyanin G chain of Stegodyphus mimosarum | KFM73503.1 | 69.722 | 3 | 4.9 | 88 |
3rd | Hemocyanin AA6 chain | P80476.1 | 72.197 | 4 | 6.2 | 67 |
3rd | Hemocyanin B chain of Stegodyphus mimosarum | KFM59357.1 | 74.335 | 3 | 4.0 | 57 |
4th | Hemocyanin F chain of Parasteatoda tepidariorum | XP_015923305.1 | 66.818 | 3 | 5.3 | 226 |
5th | Chitinase of Araneus ventricosus | AAN39100.1 | 47.608 | 1 | 2.3 | 60 |
6th | Astacin-like metalloprotease toxin of Stegodyphus mimosarum | KFM58572.1 | 46.075 | 11 | 40 | 361 |
6th | Astacin-like metalloprotease toxin 1 of Parasteatoda tepidariorum | XP_015917054.1 | 46.392 | 9 | 29.5 | 281 |
6th | Astacin-like metalloprotease toxin 1 of Parasteatoda tepidariorum | XP_021000929.1 | 45.765 | 7 | 22.6 | 232 |
6th | Arginine kinase of Parasteatoda tepidariorum | XP_015928377.1 | 46.76 | 5 | 14.2 | 138 |
7th | Hemocyanin subunit D of Latrodectus hesperus | ADV40138.1 | 38.235 | 5 | 17.4 | 225 |
7th | Hemocyanin subunit C of Latrodectus hesperus | ADV40153.1 | 37.976 | 2 | 8.2 | 70 |
7th | Putative serine protease of Latrodectus hesperus | ADV40282.1 | 38.728 | 3 | 7.4 | 57 |
Theoretical molecular weight (MW) obtained after LC-MS/MS analysis.
Score XC obtained after LC-MS/MS analysis.
3.2. RP-HPLC and LC-MS/MS analysis
BWSV was investigated using RP-HPLC with a linear gradient of 0.1% TFA in water (solvent A) and 0.085% TFA in acetonitrile (ACN) (solvent B), and the fractions were manually collected. Fig. 2 presents the 14 collected fractions. The gel showed a wide range of molecular weights (15–97 kDa). The following peaks were noted in the fractions: peak number 5 was 20–35 kDa, peak number 6 was 15–25 kDa, peak number 8 was 15–23 kDa, peak number 9 was 20–35 kDa, and peak numbers 11–14 were 20–97 kDa. Protein bands were excised from the gel and analysed with LC-MS/MS (Table 2). The protein and peptides corresponded to those identified above. However, we identified an additional protein, antigen 5-like protein in the crude spider venom. All protein sequences are available in Supplementary Table 2.
Table 2.
Fraction no. | Protein name | Accession no. | Theoretical MW (kDa)a | Number of unique peptides matched | Protein sequence coverage (%) | Score XCb |
---|---|---|---|---|---|---|
5 | Astacin-like metalloprotease toxin 1 of Parasteatoda tepidariorum | XP_015917054.1 | 46.392 | 9 | 29.5 | 281 |
6 | Arginine kinase of Parasteatoda tepidariorum | XP_015928377.1 | 46.76 | 4 | 10.33 | 138 |
8 | Putative serine protease of Latrodectus hesperus | ADV40282.1 | 38.728 | 3 | 7.4 | 57 |
8 | Chitinase of Araneus ventricosus | AAN39100.1 | 47.608 | 1 | 2.3 | 60 |
9 | Astacin-like metalloprotease toxin of Stegodyphus mimosarum | KFM58572.1 | 46.075 | 11 | 40 | 361 |
11 | α-Latroinsectotoxin precursor of Latrodectus tredecimguttatus | CAA78464.1 | 158.449 | 8 | 5.2 | 287 |
11 | U24-ctenitoxin-Pn1a of Trichonephila clavipes | PRD29014.1 | 116.247 | 6 | 40.6 | 100 |
12 | Venom allergen antigen 5-like protein of Dirofilaria immitis | AAB62535.1 | 56.6291 | 1 | 4.1 | 54 |
12 | δ-Latroinsectotoxin precursor of Latrodectus tredecimguttatus | CAA63363.1 | 136.137 | 4 | 3.9 | 134 |
13 | α -Latrocrustotoxin precursor of Latrodectus tredecimguttatus | Q9XZC0.2 | 158.752 | 3 | 2.9 | 111 |
13 | α -Latrotoxin of Latrodectus hesperus | AGD80166.1 | 154.923 | 4 | 3.8 | 97 |
14 | α -Latrotoxin precursor of Latrodectus tredecimguttatus | CAA38753.1 | 157.386 | 4 | 3.6 | 73 |
Theoretical molecular weight (MW) obtained after LC-MS/MS analysis.
Score XC obtained after LC-MS/MS analysis.
3.3. Effect of venom on crickets
Venom dissolved in PBS was intraperitoneally injected into crickets. A few minutes after venom injection, crickets presented with neurological disturbances in motion behaviours, such as slow-motion movement, constant twitching in the terminal portions of all legs, paralysis, and inability to overturn to a normal position for 30 min to 1 h. The crickets subsequently died after 24 h. These signs were obvious and consistent with neurotoxic symptoms in crickets. However, crickets in the control group did not show any neurotoxic symptoms after intraperitoneal injection. The PD50 value was 0.73 ± 0.10 μg/g body weight. Spider venom is released to prey and protects spiders, and many reports suggest that venom acts as a neurotoxin in animals and humans. According to L. geometricus crude venom shown the PD50 30 min after injection was 0.73 ± 0.10 μg/g body weight. In addition, Zobel-Thropp et al. (2014) summarized the paralytic dose (PD50) values from bioassays using spider venoms in various target species and different injection methods. However, our data can be compared only with the results from other spider venoms when the relative units are the same (μg/g). The potency of L. geometricus (0.73 μg/g) venom is greater than that of Loxosceles arizonica (2.6 μg/g), Sicarius cf. hahni (1.5 μg/g), S. rugosa (3.2 μg/g) (Zobel-Thropp et al., 2010), Plectreurys tristis (3.3 μg/g) (Zobel-Thropp et al., 2014), Phoneutria nigriventer (43.5 μg/g), and Nephilengys cruentata (24.6 μg/g) (Manzoli-Palma et al., 2003). Regarding venom potency, crickets exhibited paralytic signs within 30 min after injection of low doses of the venom and presented paralysis and even death 1 h after injection with higher doses of the venom. Information on venom potency is important when testing individual neurotoxins from L. geometricus on specific neurophysiological targets. The MS analysis revealed the presence of the latrotoxin family, especially insectotoxins. Thus, it is possible that these proteins participate in the paralysis observed in crickets.
3.4. Hyaluronidase activity
The hyaluronidase activity of spider venom was assessed using the turbidity assay. Spider venom retained activity after incubation with hyaluronidase. The solution cleared in a dose-dependent manner (data not shown). The hyaluronidase activity results are presented in Fig. 3. Hyaluronidases are a group of enzymes found throughout the animal kingdom, including venomous animals. This enzyme hydrolyses hyaluronic acid, which is a component of the extracellular matrix; thus, hyaluronidase refers to a spreading factor (Girish and Kemparaju, 2007). Hyaluronidase activity has been found in the venom of numerous spiders, such as Phoneutria nigriventer, Loxosceles reclusa (Wright et al., 1973), Hippasa partita, H. lycosina and H. agelenoides (Nagaraju et al., 2007). Moreover, Ferrer et al. (2013) reported that recombinant hyaluronidase increases the dermonecrotic effect.
The spreading property of the enzyme is hypothesized to facilitate the spreading of the toxin from the bite site to the circulatory system. In this experiment, hyaluronidase activity was assessed by measuring the reaction turbidity using various concentrations of spider venom and hyaluronic acid as a substrate. The result showed that hyaluronidase activity increased in a dose-dependent manner (Fig. 3) (p < 0.05). Spider venom is composed of many biological molecules, such as peptide toxins from the latrotoxin family, which are major neurotoxins of the brown widow spider. Individuals with spider bites exhibit local symptoms, such as erythema, swelling, pain at the bite site, and headache. We did not find hyaluronidases in the proteomic analysis because they are not a major component of venom. Nevertheless, we found hyaluronidase sequences in the transcriptomic analyses of other studies (data not shown). Hyaluronidases are a spreading factor that help toxins spread in victims, thus leading to the appearance of these symptoms.
3.5. Antibacterial activity
In the present study, the antibacterial activity of the crude spider venom against gram-positive and gram-negative bacterial strains was assessed using agar-disc diffusion assays. The inhibition zone diameter (IZD) values are shown in Table 3. As shown in the table, 30 μg of crude spider venom exhibited inhibitory activity against gram-positive bacteria (B. subtilis), with an IZD of 9.33 ± 0.5 mm, whereas another concentration of crude spider venom did not inhibit bacteria. No inhibition zone was noted for gram-negative (P. aeruginosa) bacteria (data not shown). Ampicillin and streptomycin (10 μg/disc), which were used as positive controls, exhibited a clear zone of inhibition on the plates. Venoms from other spider species also inhibited the bacterial stains. For example, hemolymph of Agelena labyrinthica inhibited both of gram-positive and gram-negative bacteria, including B. subtilis, P. aeruginosa, Shigella sp., Escherichia coli, and Staphylococcus aureus, as assessed by agar-disc diffusion (Yiğit and Benli, 2008), and purified spider venom (Crossopriza lyoni) showed broad-spectrum activity and exhibited large inhibition zones via agar disc diffusion (Gupta and Upadhyay, 2016). BWSV did not inhibit gram-negative bacteria because the crude venom contains complex components that may interfere with bacterial membrane disruption.
Table 3.
Against to Bacillus subtilis | Inhibition zone diameter (mm) |
---|---|
1) Brown widow spider venom 30 μg | 9.33 ± 0.5 |
2) Brown widow spider venom 20 μg | N/A |
3) Brown widow spider venom 10 μg | N/A |
4) Milli-Q water | N/A |
5) Ampicillin | 29 ± 1 |
6) Streptomycin | 20.67 ± 0.6 |
Spider venom consists of an abundance of small polypeptides, such as antimicrobial peptides (AMPs) (Vassilevski et al., 2009). AMPs disrupt structural and functional cellular components that are essential for pathogen survival by directly binding the cell membrane, even at micromolar concentrations (Jenssen et al., 2006). Previous reports have described antimicrobial peptides in spider venom. For example, lycotoxin I and II were isolated from Lycosa carolinensis and exhibit amphipathic α-helix structures for pore-forming activity (Yan and Adams, 1998), and Lycosin-I is a cationic peptide isolated from Lycosa singorensis that showed broad-spectrum antibacterial activity (Tan et al., 2013). Spider venom contains AMPs, and these molecules play a role in spider-prey interactions, including prey capture and protection from ingesting infectious organisms. In another study, we identified the activities of peptides of L. geometricus venom, such as anti-Alzheimer's disease peptides, anticancer peptides, and some antimicrobial peptides (data not shown); however, this venom did not present activity against gram-negative bacteria in this study. Therefore, we reviewed the literature and got the result from our transcriptomic study to predict that BWSV has antibacterial activity. The venom exhibited neurotoxic effects against insects, as well. The potency will be more informative when testing individual neurotoxins from L. geometricus on specific neurophysiological targets. Moreover, further experiments could identify peptides for drug development.
4. Conclusions
BWSV contains many biologically active compounds. The biological molecules in venom have been hypothesized to be neurotoxins, and some enzymes have important roles in venom toxicity. The effects of individual neurotoxins from L. geometricus on specific neurophysiological targets should be assessed in further studies. Specifically, antimicrobial peptides and potential insecticides in spider venom should also be assessed in further experiments, as well. In addition, the enrichment of active compounds has the potential for further development and could lead to the discovery of new compounds or insecticides.
Ethical statements
A manuscript entitled “Partial proteomic analysis of brown widow spider (Latrodectus geometricus) venom to determine the biological activities” by Pornsawan Khamtorn, Prapenpuksiri Rungsa, Nisachon Jangpromma, Sompong Klaynongsruang, Jureerut Daduang, Thanee Tessiri, Sakda Daduang has been performed according to the international, national and institutional rules considering animal experiments, clinical studies and biodiversity rights. I declare the originality of all experiments in this manuscript with full acknowledgement of the works and ideas of any other people who are cited in the article without conflicts of interest. This manuscript has not been submitted elsewhere for publication.
CRediT author statement
Pornsawan Khamtorn: conducted all the experiments, Formal analysis, Writing - original draft, Writing - review & editing. Prapenpuksiri Rungsa: Methodology. Nisachon Jangpromma: partially contributed bacteria, amino acid sequencing, bioinformatics. Sompong Klaynongsruang: partially contributed bacteria, amino acid sequencing, bioinformatics. Jureerut Daduang: partially contributed bacteria, amino acid sequencing, bioinformatics. Thanee Tessiri: supported the HPLC training, Writing - review & editing, partially help to corresponded with the journal editor. Sakda Daduang: Conceptualization, Writing - review & editing, corresponded with the journal editor.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
The authors are grateful to Khamtorn's family and Michał J. Kliniewski for their encouragement. This research was supported by The Royal Golden Jubilee Ph.D. Program, Thailand (PHD0104/2558) and partially supported by the (1) Post-Doctoral Training Program from Research and Technology Transfer Affairs, Khon Kaen University (KKU) and Graduate School, KKU, Thailand (grant no. 583334), (2) KKU Research Fund, fiscal year 2019 and (3) Thailand Research Fund (grant no. DBG6080006).
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.toxcx.2020.100062.
Contributor Information
Thanee Tessiri, Email: thates@kku.ac.th.
Sakda Daduang, Email: sakdad@kku.ac.th.
Appendix A. Supplementary data
The following are the Supplementary data to this article:
References
- Almeida R., Ferreira-Junior R.S., Chaves C.R., Barraviera B. Envenomation caused by Latrodectus geometricus in Säo Paulo State, Brazil: a case report. J. Venom. Anim. Toxins Incl. Trop. Dis. 2009;15(3):562–571. [Google Scholar]
- Choi M.B., Lee S.Y., Yoo J.S., Jun J., Kwon O. First record of western black widow spider Latrodectus Hesperus Chamberlin & Ivie, 1935 (Araneae: Theridiidae) in South Korea. Entomol. Res. 2019;49(3):141–146. [Google Scholar]
- da Silveira R.B., Pigozzo R.B., Chaim O.M., Appel M.H., Dreyfuss J.L., Toma L., Mangili O.C., Gremski W., Dietrich C.P., Nader H.B., Veiga S.S. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (Brown spider) venom gland. Biochimie. 2006;88(9):1241–1253. doi: 10.1016/j.biochi.2006.02.008. [DOI] [PubMed] [Google Scholar]
- de Roodt A.R., Lanari L.C., Laskowicz R.D., de Oliveira V.C., Irazu L.E., González A., Nicolai N., Barragán J.H., Ramallo L., López R.A., Lopardo J., Jensen O., Larrieu E., Calabró A., Vurcharchuc M.G., Lago N.R., García I., de Titto E.H., Damín C.F. Toxicity of the venom of Latrodectus (Araneae: Theridiidae) spiders from different regions of Argentina and neutralization by therapeutic antivenoms. Toxicon. 2017;130:63–72. doi: 10.1016/j.toxicon.2017.02.029. [DOI] [PubMed] [Google Scholar]
- Duan Z.G., Yan X.J., He X.Z., Zhou H., Chen P., Cao R., Xiong J.X., Hu W.J., Wang X.C., Liang S.P. Extraction and protein component analysis of venom from the dissected venom glands of Latrodectus tredecimguttatus. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2006;145(3–4):350–357. doi: 10.1016/j.cbpb.2006.08.006. [DOI] [PubMed] [Google Scholar]
- Duan Z., Yan X., Cao R., Liu Z., Wang X., Liang S. Proteomic analysis of Latrodecctus trecimguttatus venom for uncovering potential Latrodectism: related proteins. J. Biochem. Mol. Toxicol. 2008;22(5):328–336. doi: 10.1002/jbt.20244. [DOI] [PubMed] [Google Scholar]
- Ferrer V.P., de Mari T.L., Gremski L.H., Silva D.T., da Silveira R.B., Gremski W., Chaim O.M., Senff-Ribeiro A., Nader H.B., Veiga S.S. A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization. PLoS Neglected Trop. Dis. 2013;7(5):e2206–2217. doi: 10.1371/journal.pntd.0002206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Girish K.S., Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 2007;80(21):1921–1943. doi: 10.1016/j.lfs.2007.02.037. [DOI] [PubMed] [Google Scholar]
- Goddard J., Upshaw S., Held D., Johnnson K. Severe reaction from envenomation by the brown widow spider, Latrodectus geometricus (Araneae: Theridiidae) South. Med. J. 2008;101(12):1269–1270. doi: 10.1097/SMJ.0b013e31817f4d89. [DOI] [PubMed] [Google Scholar]
- Grishin E.V., Himmelreich N.H., Pluzhnikov K.A., Pozdnyakova N.G., Storchak L.G., Volkova T.M., Woll P.G. Modulation of functional activities of the neurotoxin from black widow spider venom. FEBS Lett. 1993;336(2):205–207. doi: 10.1016/0014-5793(93)80803-3. [DOI] [PubMed] [Google Scholar]
- Gupta R.K., Upadhyay R.K. Antimicrobial activity of purified toxins from Crossopriza lyoni (spider) against certain bacteria and fungi. J. Biosci. Med. 2016;4:1–9. [Google Scholar]
- Heawchaiyaphum C., Pientong C., Phusingha P., Vatanasapt P., Promthet S., Daduang J., Teeramatwanich W., Kongyingyoes B., Chuerduangphui J., Ekalaksananan T. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches. J. Proteomics. 2018;173:52–61. doi: 10.1016/j.jprot.2017.11.022. [DOI] [PubMed] [Google Scholar]
- Jelinek G.A. Widow spider envenomation (latrodectism): a worldwide problem. Wilderness Environ. Med. 1997;8(4):226–231. doi: 10.1580/1080-6032(1997)008[0226:wselaw]2.3.co;2. [DOI] [PubMed] [Google Scholar]
- Jenssen H., Hamill P., Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006;19:491–511. doi: 10.1128/CMR.00056-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khan A.A., Afzal M., Raza A.M., Khan A.M., Iqbal J., Tahir H.M., Qureshi J.A., Khaliq A., Zia-ul-Haq M., Aqeel M.A. Toxicity of botanicals and selective insecticides to Asian citrus psylla, Diaphorina citri K. (Homoptera: Psyllidae) in laboratory conditions. Jokull J. 2013;63(8):52–72. [Google Scholar]
- Krasnoperov V.G., Shamotienko O.G., Grishin E.V. Isolation and properties of insect-specific neurotoxins from venoms of the spider Lactodectus mactans tredecimguttatus. Bioorg. Khim. 1990;16(8):1138–1140. [PubMed] [Google Scholar]
- Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Lei Q., Yu H., Peng X., Yan S., Wang J., Yan Y., Wang X. Isolation and preliminary characterization of proteinaceous toxins with insecticidal and antibacterial activities from black widow spider (L. tredecimguttatus) eggs. Toxins. 2015;7(3):886–899. doi: 10.3390/toxins7030886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manzoli-Palma M.F., Gobbi N., Palma M.S. Insects as biological models to assay spider and scorpion toxicity. J. Venom. Anim. Toxins Incl. Trop. Dis. 2003;9:174–185. [Google Scholar]
- Muslimin M., Wilson J.J., Ghazali A.R.M., Braima K.A., Jeffery J., Wan-Nor F., Alaa-Eldin M.E., Mohd-Zin S., Wan-Yusoff W.S., Norma-Rashid Y., Lau Y.L., Rohela M., Abdul-Aziz N.M. First report of brown widow spider sightings in Peninsular Malaysia and notes on its global distribution. J. Venom. Anim. Toxins Incl. Trop. Dis. 2015;21(11):1–8. doi: 10.1186/s40409-015-0010-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagaraju S., Devaraja S., Kemparaju K. Purification and properties of hyaluronidase from Hippasa partita (funnel web spider) venom gland extract. Toxicon. 2007;50(3):383–393. doi: 10.1016/j.toxicon.2007.04.007. [DOI] [PubMed] [Google Scholar]
- Pan T.L., Grӧger H., Schmid V., Spring J. A toxin homology domain in an astacin-like metalloproteinase of the jellyfish Podocoryne carnea with a dual role in digestion and development. Dev. Gene. Evol. 1998;208(5):259–266. doi: 10.1007/s004270050180. [DOI] [PubMed] [Google Scholar]
- Saez N.J., Senff S., Jensen J.E., Er S.Y., Herzig V., Rash L.D., King G.F. Spider-venom peptides as therapeutics. Toxins. 2010;2(12):2851–2871. doi: 10.3390/toxins2122851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shackelford R., Veillon D., Maxwell N., LaChance L., Jusino T., Cotelingam J., Carrington P. The black widow spider bite: differential diagnosis, clinical manifestations, and treatment options. J. La. State Med. Soc. 2015;167(2):74–78. [PubMed] [Google Scholar]
- Smith D.S., Russell F.E. Pergamon; Oxford: 1966. Structure of the Venom Gland of the Black Widow Spider Latrodectus Mactans. [Google Scholar]
- Tan H., Ding X., Meng S., Liu C., Wang H., Xia L., Liu Z., Liang S. Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis. Curr. Mol. Med. 2013;13:900–910. doi: 10.2174/15665240113139990045. [DOI] [PubMed] [Google Scholar]
- Uawonggul N., Sukprasert S., Incamnoi P., Patramanon R., Thammasirirak S., Presscharram S., Bunyatratchata W., Kuapresert B., Daduang J., Daduang S. Bacterial overexpression of recombinant Heteroscorpine-1 (rHS-1), a toxin from Heterometrus laoticus scorpion venom: Trends for antibacterial application and antivenom production. Biochem. Genet. 2014;52(11–12):459–473. doi: 10.1007/s10528-014-9660-y. [DOI] [PubMed] [Google Scholar]
- Vassilevski A.A., Kozlov S.A., Grishin E.V. Molecular diversity of spider venom. Biochemistry (Mosc.) 2009;74:1505–1534. doi: 10.1134/s0006297909130069. [DOI] [PubMed] [Google Scholar]
- Villas-Boas I.M., Gonçalves-de-Andrade R.M., Pidde-Queiroz G., Assaf S.L.M.R., Portaro F.C.V., Sant'Anna O.A.S., van den Berg C.W., Tambourgi D.V. Premolis semirufa (Walker, 1856) Envenomation, disease affecting rubber tappers of the Amazon: searching for caterpillar-bristles toxic components. PLoS Neglected Trop. Dis. 2012;6(2):e1531–1540. doi: 10.1371/journal.pntd.0001531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Spider Catalog Natural history Museum bern. 2020. http://wsc.nmbe.ch Accessed date:
- Wright R.P., Elgert K.D., Campell B.J., Barrett J.T. Hyaluronidase and esterase activities of the venom of poisonous brown recluse spider. Arch. Biochem. Biophys. 1973;59:415–426. doi: 10.1016/0003-9861(73)90469-4. [DOI] [PubMed] [Google Scholar]
- Yan L., Adams M.E. Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis. J. Biol. Chem. 1998;273:2059–2066. doi: 10.1074/jbc.273.4.2059. [DOI] [PubMed] [Google Scholar]
- Yan S., Wang X. Recent advances in research on widow spider. Toxins. 2015;7(12):5055–5067. doi: 10.3390/toxins7124862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yan Y., Li J., Zhang Y., Peng X., Guo T., Wang J., Hu W., Duan Z., Wang X. Physiological and biochemical characterization of egg extract of black widow spider to uncover molecular basis of egg toxicity. Biol. Res. 2014;47:1–17. doi: 10.1186/0717-6287-47-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yiğit N., Benli M. The antibacterial activity of hemolymph of spider, Agelena labyrinthica (Araneae: Agelenidae) J, Forest Fact. 2008;8(2):120–124. [Google Scholar]
- Zobel-Thropp P.A., Bodner M.R., Binford G.J. Comparative analyses of venoms from American and African Sicarius spider that differ in sphingomyelinase D activity. Toxicon. 2010;55:1274–1282. doi: 10.1016/j.toxicon.2010.01.019. [DOI] [PubMed] [Google Scholar]
- Zobel-Thropp P.A., Thomas E.Z., David C.L., Breci L.A., Binford G.J. Pletreurys tristis venome: a proteomic and transcriptomic analysis. J. Venom Res. 2014;5:33–47. [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.